DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 05 · Volume 35 · September 2002 DOI: 10.1055/s-002-2163

Original Paper

  • 159
    Seifert, J.; Metzner, C.; Paetzold, W.; Borsutzky, M.; Passie, T.; Rollnik, J.; Wiese, B.; Emrich, H. M.; Schneider, U.:

    Detoxification of Opiate Addicts with Multiple Drug Abuse: a Comparison of Buprenorphine vs. Methadone

  • 165
    Riemann, D.; Voderholzer, U.; Cohrs, S.; Rodenbeck, A.; Hajak, G.; Rüther, E.; Wiegand, M. H.; Laakmann, G.; Baghai, T.; Fischer, W.; Hoffmann, M.; Hohagen, F.; Mayer, G.; Berger, M.:

    Trimipramine in Primary Insomnia: Results of a Polysomnographic Double-Blind Controlled Study

  • 175
    Ueda, N.; Yoshimura, R.; Shinkai, K.; Nakamura, J.:

    Plasma Levels of Catecholamine Metabolites Predict the Response to Sulpiride or Fluvoxamine in Major Depression

  • 182
    Reuter, M.; Siegmund, A.; Netter, P.:

    The Trigonometric Responder Approach: A New Method for Detecting Responders to Pharmacological or Experimental Challenges

  • 190
    Adler, G.; Grieshaber, S.; Faude, V.; Thebaldi, B.; Dressing, H.:

    Clozapine in Patients with Chronic Schizophrenia: Serum Level, EEG and Memory Performance

    • Short Communication

  • 195
    Samochowiec, J.; Kucharska-Mazur, J.; Rybakowski, F.; Ostapowicz, A.; Horodnicki, J.; Rozpara, M.; Kamiński, R.; Skrzypińska, A.; Arentowicz, G.; Rommelspacher, H.; Schmidt, L.-G.:

    Norepinephrine Transporter Polymorphism and Personality Trait of Reward Dependence in Male Alcoholics

    • Case Report

  • 197
    Jain, V.; Swartz, C. M.:

    Charcoal Enhancement of Treatment for Tricyclic-Induced Mania

  • 200
    Dietz, A.; Frölich, L.:

    Mefloquine-induced Paranoid Psychosis and Subsequent Major Depression in a 25-year-old Student